Articles:

How should we respond to the worldwide diabetes epidemic?

CM Clark
Diabetes Care 1998 21: 475-476. [PDF]  

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study

MJ Tikkanen, M Laakso, M Ilmonen, E Helve, E Kaarsalo, E Kilkki, and J Saltevo
Diabetes Care 1998 21: 477-481. [Abstract] [PDF]  

Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients

K Yoshioka, M Imanishi, Y Konishi, T Sato, S Tanaka, G Kimura, and S Fujii
Diabetes Care 1998 21: 482-486. [Abstract] [PDF]  

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

AC Desfaits, O Serri, and G Renier
Diabetes Care 1998 21: 487-493. [Abstract] [PDF]  

Fish oil and glycemic control in diabetes. A meta-analysis

CE Friedberg, MJ Janssen, RJ Heine, and DE Grobbee
Diabetes Care 1998 21: 494-500. [Abstract] [PDF]  

Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control

IM el-Kebbi, DC Ziemer, DL Gallina, and LS Phillips
Diabetes Care 1998 21: 501-505. [Abstract] [PDF]  

The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications

G Yosipovitch, E Hodak, P Vardi, I Shraga, M Karp, E Sprecher, and M David
Diabetes Care 1998 21: 506-509. [Abstract] [PDF]  

Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)

L Agrawal, NV Emanuele, C Abraira, WG Henderson, SR Levin, CT Sawin, CK Silbert, FQ Nuttall, JP Comstock, and JA Colwell
Diabetes Care 1998 21: 510-515. [Abstract] [PDF]  

Serum leptin levels in smokers with type 2 diabetes

M Yoshinari, M Wakisaka, and M Fujishima
Diabetes Care 1998 21: 516-517. [Abstract] [PDF]  

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994

MI Harris, KM Flegal, CC Cowie, MS Eberhardt, DE Goldstein, RR Little, HM Wiedmeyer, and DD Byrd-Holt
Diabetes Care 1998 21: 518-524. [Abstract] [PDF]  

Childhood diabetes in China. Enormous variation by place and ethnic group

Z Yang, K Wang, T Li, W Sun, Y Li, YF Chang, JS Dorman, and RE LaPorte
Diabetes Care 1998 21: 525-529. [Abstract] [PDF]  

Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes

JY Park, HK Kim, YE Chung, SW Kim, SK Hong, and KU Lee
Diabetes Care 1998 21: 530-534. [Abstract] [PDF]  

The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM

AE Gold, R Reilly, J Little, and JD Walker
Diabetes Care 1998 21: 535-538. [Abstract] [PDF]  

Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study

AM Adlerberth, A Rosengren, and L Wilhelmsen
Diabetes Care 1998 21: 539-545. [Abstract] [PDF]  

The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry

B Berger, G Stenstrom, YF Chang, and G Sundkvist
Diabetes Care 1998 21: 546-548. [Abstract] [PDF]  

Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project

A Grandinetti, HK Chang, MK Mau, JD Curb, EK Kinney, R Sagum, and RF Arakaki
Diabetes Care 1998 21: 549-554. [Abstract] [PDF]  

Physical activity and NIDDM in African-Americans. The Pitt County Study

SA James, L Jamjoum, TE Raghunathan, DS Strogatz, ED Furth, and PG Khazanie
Diabetes Care 1998 21: 555-562. [Abstract] [PDF]  

Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project

SO Ebbesson, CD Schraer, PM Risica, AI Adler, L Ebbesson, AM Mayer, EV Shubnikof, J Yeh, OT Go, and DC Robbins
Diabetes Care 1998 21: 563-569. [Abstract] [PDF]  

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients

G Schernthaner, W Wein, K Sandholzer, S Equiluz-Bruck, PC Bates, and MA Birkett
Diabetes Care 1998 21: 570-573. [Abstract] [PDF]  

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM)

C Abraira, WG Henderson, JA Colwell, FQ Nuttall, JP Comstock, NV Emanuele, SR Levin, CT Sawin, and CK Silbert
Diabetes Care 1998 21: 574-579. [Abstract] [PDF]  

Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy

A Schindl, M Schindl, H Schon, R Knobler, L Havelec, and L Schindl
Diabetes Care 1998 21: 580-584. [Abstract] [PDF]  

Validation of home blood glucose meters with respect to clinical and analytical approaches

GA Brunner, M Ellmerer, G Sendlhofer, A Wutte, Z Trajanoski, L Schaupp, F Quehenberger, P Wach, GJ Krejs, and TR Pieber
Diabetes Care 1998 21: 585-590. [Abstract] [PDF]  

An electronic case manager for diabetes control

LF Meneghini, AM Albisser, RB Goldberg, and DH Mintz
Diabetes Care 1998 21: 591-596. [Abstract] [PDF]  

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM

P Tatti, M Pahor, RP Byington, P Di Mauro, R Guarisco, G Strollo, and F Strollo
Diabetes Care 1998 21: 597-603. [Abstract] [PDF]  

Muscular endurance in long-term IDDM patients

H Andersen
Diabetes Care 1998 21: 604-609. [Abstract] [PDF]  

The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population

JR Erbey, LH Kuller, DJ Becker, and TJ Orchard
Diabetes Care 1998 21: 610-614. [Abstract] [PDF]  

Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy

K Ohgaki, K Nakano, H Shigeta, Y Kitagawa, N Nakamura, K Iwamoto, M Makino, Y Takanashi, S Kajiyama, and M Kondo
Diabetes Care 1998 21: 615-618. [Abstract] [PDF]  

Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up

T Yamanouchi, T Kawasaki, T Yoshimura, T Inoue, E Koshibu, N Ogata, H Funato, I Akaoka, and H Miyashita
Diabetes Care 1998 21: 619-624. [Abstract] [PDF]  

Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers

E Faglia, F Favales, A Quarantiello, P Calia, P Clelia, G Brambilla, A Rampoldi, and A Morabito
Diabetes Care 1998 21: 625-630. [Abstract] [PDF]  

Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension

D Giugliano, R Marfella, R Acampora, R Giunta, L Coppola, and F D'Onofrio
Diabetes Care 1998 21: 631-636. [Abstract] [PDF]  

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment

TM Davis, RW Parsons, RJ Broadhurst, MS Hobbs, and K Jamrozik
Diabetes Care 1998 21: 637-640. [Abstract] [PDF]  

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

RS Elkeles, JR Diamond, C Poulter, S Dhanjil, AN Nicolaides, S Mahmood, W Richmond, H Mather, P Sharp, and MD Feher
Diabetes Care 1998 21: 641-648. [Abstract] [PDF]  

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study

G Imperatore, G Riccardi, C Iovine, AA Rivellese, and O Vaccaro
Diabetes Care 1998 21: 649-654. [Abstract] [PDF]  

Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points

RM Califf and CB Granger
Diabetes Care 1998 21: 655-657. [PDF]  

International Diabetes Federation Meeting, 1997, and Metropolitan Diabetes Society of New York Meeting, November 1997. Approaches to treatment and other topics in type 1 diabetes; genetic heterogeneity of diabetes

ZT Bloomgarden
Diabetes Care 1998 21: 658-665. [PDF]  

Glucose tolerance, insulin sensitivity, and the homeostasis model assessment method

TW van Haeften
Diabetes Care 1998 21: 673-674. [PDF]  

Screening for gestational diabetes. What is the no-show rate?

R Hitchman, G Mathur, and A McElduff
Diabetes Care 1998 21: 674-675. [PDF]  

Constant infused glucose regimen during the recovery phase of diabetic ketoacidosis in children and adolescents with IDDM

S Amemiya
Diabetes Care 1998 21: 676-677. [PDF]  

Letters:

Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population

A Ramachandran, C Snehalatha, E Latha, and V Vijay
Diabetes Care 1998 21: 666-667. [PDF]  

Assessing the antihyperglycemic effect of acarbose. Solid or liquid test meal?

TM Wolever
Diabetes Care 1998 21: 667-668. [PDF]  

Gestational diabetes mellitus is associated with an increase in the total concentration of amylin molecules

NJ Wareham, R Swinn, MS Fineman, JE Koda, K Taylor, DE Williams, and SO Rahilly
Diabetes Care 1998 21: 668-669. [PDF]  

A critical issue. Intensive insulin treatment and macrovascular disease

C Abraira, JA Colwell, F Nuttall, N Emanuele, J Comstock, S Levin, C Sawin, and C Silbert
Diabetes Care 1998 21: 669-671. [PDF]  

Diagnosis of diabetes in cystic fibrosis and thalassemia major

RW Holl, C Buck, H Cario, A Wolf, A Thon, E Kohne, and KM Debatin
Diabetes Care 1998 21: 671-672. [PDF]  

Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor

R Hayashi, N Hayakawa, M Makino, M Nagata, H Kakizawa, K Uchimura, M Hamada, T Aono, T Fujita, R Shinohara, A Nagasaka, and M Itoh
Diabetes Care 1998 21: 672-673. [PDF]  

Antibodies to GAD in elderly patients with previously diagnosed NIDDM

M Fukui, N Nakamura, K Nakano, M Sawada, O Aoji, H Obayashi, H Shigeta, and M Kondo
Diabetes Care 1998 21: 675-676. [PDF]  

Case report. Pseudohepatotoxicity of metformin

AL Swislocki and R Noth
Diabetes Care 1998 21: 677-678. [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.